Indication for 1,25-dihydroxyvitamin D3 (calcitriol) administration is:

Questions 265

ATI RN

ATI RN Test Bank

ATI Pharmacology Across the Lifespan Questions

Question 1 of 5

Indication for 1,25-dihydroxyvitamin D3 (calcitriol) administration is:

Correct Answer: A

Rationale: In this question, the correct answer is A) Vitamin D resistance. 1,25-dihydroxyvitamin D3 (calcitriol) is the active form of vitamin D in the body. Administering calcitriol is indicated in cases of vitamin D resistance, where the body is unable to respond effectively to vitamin D. By providing the active form directly, the body can bypass the resistance and still utilize vitamin D for its various functions, such as calcium absorption in the gut and bone health. Now, let's analyze why the other options are incorrect: B) Elevated skeletal turnover: This is not an indication for administering calcitriol. Elevated skeletal turnover may be seen in conditions like osteoporosis, but calcitriol is not the primary treatment for this. C) Hypercalcemia of malignancy: Administering calcitriol in hypercalcemia of malignancy would be contraindicated as it could further increase calcium levels in the blood. D) Hypophosphatemia: Calcitriol is not indicated for treating hypophosphatemia. In fact, administering calcitriol in hypophosphatemia can worsen the condition by increasing phosphate excretion in the urine. Educational context: Understanding the indications for administering medications like calcitriol is crucial for healthcare professionals to ensure safe and effective patient care. Knowing when to use a medication and when not to can prevent adverse effects and optimize treatment outcomes. Being able to differentiate between various indications helps in making informed clinical decisions.

Question 2 of 5

Correct statements about etidronate include all of the following, EXCEPT:

Correct Answer: C

Rationale: In this question, the correct answer is C) 2nd generation bisphosphonate (amino-bisphosphonate) as being incorrect about etidronate. Etidronate is a 1st generation bisphosphonate, not a 2nd generation one. Etidronate has a skeletal half-life of around 100 days, making statement A correct. Statement B is incorrect because the bioavailability of etidronate decreases with increasing doses due to non-linear absorption kinetics. Statement D is correct as etidronate is indeed classified as a 1st generation bisphosphonate. Educationally, understanding the classification and characteristics of bisphosphonates like etidronate is crucial for pharmacology students and healthcare professionals. Knowing the differences between generations of bisphosphonates helps in selecting appropriate medications for osteoporosis and other bone-related conditions based on factors like efficacy, side effect profiles, and patient-specific considerations.

Question 3 of 5

Which of the oral magnesium preparations is often the preparation of choice:

Correct Answer: C

Rationale: In the context of pharmacology, selecting the appropriate oral magnesium preparation is crucial for ensuring optimal therapeutic outcomes. In this scenario, the correct answer is option C, MagneB6 (Mg pidolate / Mg lactate + pyridoxine hydrochloride), as it offers a combination of magnesium salts along with pyridoxine hydrochloride (Vitamin B6). MagneB6 is often the preparation of choice due to several reasons: 1. **Enhanced Absorption**: MagneB6 contains magnesium in forms that are more readily absorbed by the body compared to other oral magnesium preparations. 2. **Synergistic Effect**: The addition of pyridoxine hydrochloride in MagneB6 can enhance the overall therapeutic effect, especially in conditions where magnesium and Vitamin B6 deficiencies coexist. 3. **Improved Tolerability**: Some individuals may experience gastrointestinal side effects with other magnesium salts, but MagneB6 may be better tolerated due to its formulation. Now, let's discuss why the other options are incorrect: - **Option A - Magnesium lactate**: While magnesium lactate is a form of magnesium supplement, it may not always be the preparation of choice due to variable absorption rates and potential limitations in therapeutic efficacy compared to MagneB6. - **Option B - Magnesium oxide**: Magnesium oxide is known for its high magnesium content but has poor bioavailability, which can limit its effectiveness in clinical practice. - **Option D - All of the above**: This option is incorrect as not all oral magnesium preparations are considered equal in terms of bioavailability, efficacy, and tolerability. Educationally, understanding the rationale behind selecting the appropriate oral magnesium preparation is essential for healthcare professionals to make informed decisions when managing patients requiring magnesium supplementation. By grasping the pharmacokinetics, pharmacodynamics, and formulation specifics of different magnesium salts, healthcare providers can tailor treatment plans to maximize therapeutic benefits and minimize adverse effects.

Question 4 of 5

All of the following statements regarding diuretics are true, EXCEPT:

Correct Answer: A

Rationale: In this question, option A is incorrect because carbonic anhydrase inhibition actually decreases reabsorption of NaHCO3, leading to diuresis. Let's break down the rationale: A) Incorrect: Carbonic anhydrase inhibition, as seen with drugs like acetazolamide, impedes the conversion of carbon dioxide and water to bicarbonate and hydrogen ions in the proximal convoluted tubule. This disruption results in decreased reabsorption of sodium bicarbonate and subsequently leads to increased excretion of sodium and water. B) Correct: Loop diuretics such as furosemide work by inhibiting the Na+/K+/2Cl- cotransporter in the thick ascending loop of Henle, thus reducing sodium reabsorption and promoting diuresis. C) True: The effectiveness and potency of diuretics are indeed influenced by their site of action along the nephron. For instance, loop diuretics are more potent than thiazide diuretics due to their action at the loop of Henle, where reabsorption of sodium is actively inhibited. D) True: Hydrochlorothiazide, a thiazide diuretic, enhances calcium reabsorption in the distal convoluted tubule, leading to decreased urinary calcium excretion. Educational context: Understanding the mechanisms of action of diuretics is crucial in pharmacology as it helps healthcare providers select the most appropriate diuretic based on a patient's condition and needs. This knowledge also aids in predicting potential side effects and drug interactions, optimizing patient care.

Question 5 of 5

The drug needs aldosterone present in order to be effective:

Correct Answer: B

Rationale: In this scenario, the correct answer is B) Amiloride (Midamor) because it is a potassium-sparing diuretic that works by blocking the epithelial sodium channel in the late distal convoluted tubule and collecting ducts of the nephron. This action inhibits sodium reabsorption and potassium excretion, leading to decreased potassium loss and increased potassium retention. Option A) Hydrochlorothiazide (HydroDiuril) is a thiazide diuretic that acts on the early distal convoluted tubule by inhibiting sodium and chloride reabsorption. It does not require aldosterone for its mechanism of action. By understanding the mechanism of action of these diuretics and their specific sites of action in the nephron, students can grasp how different classes of diuretics affect electrolyte balance and fluid excretion in the body. This knowledge is crucial for nursing students to make informed decisions when administering diuretics to patients with varying conditions such as hypertension, heart failure, or edema.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions